Dr. Lloyd Harvey completed his MD, PhD at the University of Pittsburgh-Carnegie Mellon University Medical Scientist Training Program under Dr. Stephen Y. Chan. His work leveraged large, multidimensional genomic and metabolomic datasets to define a role for lysosomal control of sterol metabolism at the endothelium in pulmonary arterial hypertension. His work led to the computational definition and synthesis of a novel agent targeting this pathway to reverse disease in vitro and in vivo.